Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkins Lymphoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
301-311
Author(s):
A. J. Grillo-Lopez, B.K. Dallaire, A. McClure, R. Weaver, C. Varns, A. Wei, R. Allen, D. Lee, D. Shen, J. Leonard, P.Multani and C.A.White
Zevalin™: 90Yttrium Labeled Anti-CD20 (Ibritumomab Tiuxetan), a New Treatment for Non-Hodgkin ’ s Lymphoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
341-349
Author(s):
C. Krasner and R.M. Joyce
Antibody Therapy of Acute and Chronic Leukemias
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
357-367
Author(s):
Spero R. Cataland, Margaret Lucas and John C. Byrd
Future Approaches for Treating Hematologic Disease
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
369-382
Author(s):
M. Reff, G. Braslawsky and N. Hanna
Helicase Domain Containing Proteins in Human Disorders
Journal:
Current Genomics
Volume:
2
Page:
305-324
Author(s):
Adayabalam S. Balajee and Colette ApRhys
Turner Syndrome : How Is It Made Up?
Journal:
Current Genomics
Volume:
2
Page:
357-377
Author(s):
Tsutomu Ogata
Micro Arrays and Biochips: Applications and Potential in Genomics and Proteomics
Journal:
Current Genomics
Volume:
2
Page:
399-415
Author(s):
Tuan Vo-Dinh and Minoo Askari
Heterodimeric Amino Acid Transporters: Molecular Biology and Pathological and Pharmacological Relevance
Journal:
Current Drug Metabolism
Volume:
2
Page:
339-354
Author(s):
Yoshikatsu Kanai and Hitoshi Endou
The MRP Family and Anticancer Drug Metabolism
Journal:
Current Drug Metabolism
Volume:
2
Page:
367-377
Author(s):
T. Suzuki, K. Nishio and S. Tanabe
Interactions of Liposomes with Cells In Vitro and In Vivo: Opsonins and Receptors
Journal:
Current Drug Metabolism
Volume:
2
Page:
397-409
Author(s):
Tatsuhiro Ishida, Hideyoshi Harashima and Hiroshi Kiwada